Infliximab (Remicade) Lyophilized Powder from Germany
Infliximab is a chimeric monoclonal antibody against TNF-alpha for psoriasis and ulcerative colitis. HTS 3002.15.00.11 applies to this biotech-derived immunological product in measured retail doses for reconstitution.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Document lyophilization process and monoclonal origin; FDA requires stability post-reconstitution
• Declare as 'immunological product containing monoclonal antibodies' explicitly
• Avoid classifying with general cytokines; specify antibody fraction